ASTHOConnects: Infectious Disease Consequences of Opioid Use

Dec 13, 2018 02:00pm -
Dec 13, 2018 03:00pm

Event Details

Event Description

Join ASTHO and CDC to learn about opportunities to assess, prepare, and implement programs that prevent the spread of HIV, viral hepatitis, and other infectious diseases related to the opioid epidemic. Expert panelists will discuss evidence-based practices that reduce the harmful health outcomes associated with injection drug use and link clients to treatment programs.

State and local representatives from Vermont will share their perspectives on policy levers and activities needed at the community level to implement syringe services programs (SSPs). Representatives will share lessons learned related to developing and implementing SSPs and building linkages to treatment for substance misuse.

Expert Panel:

  • Alice K. Asher, Epidemiologist, Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
  • Daniel J. Daltry, Program Chief, HIV/ STD/ Hepatitis Program, Vermont Department of Health
  • Grace Keller, Program Coordinator, Howard Center Safe Recovery


By the end of the webinar, participants will be able to:

  • Describe the infectious disease consequences of the opioid epidemic, including HIV, hepatitis C, rising MRSA infections, endocarditis, and hepatitis A.
  • Find resources and evidence-based tools that help them understand their state’s vulnerability to the infectious disease consequences of the opioid crisis.
  • Explain SSPs and how these programs benefit clients, communities, and public health and healthcare systems.
  • Apply what they learn about how Vermont is using policies and partnerships to reduce the harmful consequences of opioid use.

Event Type:ASTHOConnects
Early registration ends on Nov 19, 2018.
Regular registration starts on Nov 20, 2018 and ends on Dec 12, 2018.
Late registration starts on Dec 13, 2018.

Register for this event